Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > ImmunityBio stock price
View:
Post by Camphikefish on Dec 07, 2021 11:05pm

ImmunityBio stock price

Hoping Enrique or someone can expand on the 72% CR ImmunityBio reported from their phase 2 150 + patient NMIBC trial as it relates to their current stock price . With so many patients disease free at 12 months it seems this stock would've gone sharply higher . I tried my best to research, read,  and understand before this posting however, I realize I need to be enlightened ! Honestly I had never heard of this stock before someone posted about it yesterday or the day before . It concerns me . Please put me at ease !
Comment by enriquesuave on Dec 07, 2021 11:23pm
Immunity Bio is doing a combination trial with both BCG plus their drug N-803.  2 drugs and 15 treatments and maintenance treatments to follow.  Very good results as 72% show a CR at any time ( between 3-6 months) and 59% of those patients maintain their CR status for 12 or more months.  So 59% of 72% is equal to a 42% 12 or 15 months CR rate  excellent and beats Vicinium and ...more  
Comment by CancerSlayer on Dec 08, 2021 3:11am
ImmunityBio is also investigating N-803 as a single-agent treatment, but I have not seen any interim results reported on this cohort.  It wouldn't surprise me to see a significantly less robust CR rate in this group.   Although we are not scientifically comparing apples to apples when considering our single-agent ACT vs the N-803 combo treatment, the reality is...the N-803 combo ...more  
Comment by wildbird1 on Dec 08, 2021 8:16am
Thanks Camphikefish..I love it when peoples bring new treatments... it give us a chance to compare to TLT. After googling N-803 & BCG, I found 2 quotes that are very interesting... 1) For N-803 & BCG...Eligibility criteria included histologically confirmed non-muscle invasive urothelial carcinoma of intermediate or high risk who had not received prior treatment with intravesical BCG ...more  
Comment by wildbird1 on Dec 08, 2021 10:35am
Just a little complementary question $?????. If ImmunityBio share price did spike to $40.00 with a treatment that treat only 10% of Bladder cancer patients. TLT could easily treat 100% of Bladder cancer patients and other cancers. Were will the SP spike to $?????.
Comment by menoalittle on Dec 08, 2021 10:42am
>> Were will the SP spike to $?????. the moon, baby.  the moon... lol.
Comment by robertshaw on Dec 08, 2021 10:49am
if only Blowjobjoe's bosses go to hell 1st...
Comment by Lesalpes29 on Dec 08, 2021 11:02am
My bid is in at .34. Small buy again.
Comment by Lesalpes29 on Dec 08, 2021 11:09am
Got it.
Comment by robertshaw on Dec 08, 2021 12:35pm
Blowjobjoe's bosses just started their dump again on 12:00, same timing as yesterday... Watch out...
Comment by Rumpl3StiltSkin on Dec 08, 2021 11:01am
Well, we need to know what was the Float? when their stock price spiked to $40ish before we start to calculate TLT's lift off, Lol.
Comment by jewel9m on Dec 08, 2021 11:57am
Well, there float right now is 400million. So would have been close tp that 1 year ago I assume?
Comment by Rumpl3StiltSkin on Dec 08, 2021 12:32pm
Wow, that is quite a float for a stock to spike to $40?? I'm going to have to look into this more.
Comment by Rumpl3StiltSkin on Dec 08, 2021 12:41pm
The Majority of that float 80% was owned by one chinese investor. So the 'real' float for Immunity Bio was much less... And it was a nasdaq stock. You could imagine what would happen to TLT if it were on the Naz with our superior tech.